These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19046753)

  • 1. Cervical tumor caused by the sexually mature stage of Fasciola hepatica.
    Marcos LA; Légua P; Sánchez J; Espinoza JR; Yi P; Tantaleán M
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):318-20. PubMed ID: 19046753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
    Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic vasculitis associated with Fasciola hepatica infection.
    Llanos C; Soto L; Sabugo F; Gallegos I; Valenzuela O; Verdaguer J; Cuchacovich M
    Scand J Rheumatol; 2006; 35(2):143-6. PubMed ID: 16641050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody sandwich immunoassay detection of coproantigen to evaluate the efficacy of treatment in natural ovine fasciolosis.
    Duménigo BE; Mezo M
    Res Vet Sci; 1999 Apr; 66(2):165-7. PubMed ID: 10208896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola hepatica infection: clinical and radiological findings in pediatric patients.
    Karadağ-Öncel E; Ozsürekçi Y; Ozkaya-Parlakay A; Celik M; Cengiz AB; Haliloğlu M; Ceyhan M; Kara A
    Turk J Pediatr; 2012; 54(4):362-7. PubMed ID: 23692716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica.
    Valero MA; Perez-Crespo I; Periago MV; Khoubbane M; Mas-Coma S
    Acta Trop; 2009 Aug; 111(2):150-9. PubMed ID: 19375410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFficacy of albendazole for treatment of naturally acquired fasciola hepatica in calves.
    Malone JB; Smith PH; Loyacano AF; Hembry FG; Brock LT
    Am J Vet Res; 1982 May; 43(5):879-81. PubMed ID: 7091853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis.
    Marcos LA; Tagle M; Terashima A; Bussalleu A; Ramirez C; Carrasco C; Valdez L; Huerta-Mercado J; Freedman DO; Vinetz JM; Gotuzzo E
    Am J Trop Med Hyg; 2008 Feb; 78(2):222-7. PubMed ID: 18256419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
    Yilmaz B; Köklü S; Gedikoglu G
    Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans.
    Espinoza JR; Maco V; Marcos L; Saez S; Neyra V; Terashima A; Samalvides F; Gotuzzo E; Chavarry E; Huaman MC; Bargues MD; Valero MA; Mas-Coma S
    Am J Trop Med Hyg; 2007 May; 76(5):977-82. PubMed ID: 17488926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
    Millán JC; Mull R; Freise S; Richter J;
    Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of radiologically diagnosed pediatric Fasciola hepatica].
    Deveci U; Oztürk T; Ustün C
    Turkiye Parazitol Derg; 2011; 35(2):117-9. PubMed ID: 21776600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasciola hepatica: comparison of the sedimentation and FLOTAC techniques for the detection and quantification of faecal egg counts in rats.
    Duthaler U; Rinaldi L; Maurelli MP; Vargas M; Utzinger J; Cringoli G; Keiser J
    Exp Parasitol; 2010 Oct; 126(2):161-6. PubMed ID: 20434442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fascioliasis: a case of hyperinfection and an update for clinicians.
    Arauco R; Zetola NM; Calderon F; Seas C
    Foodborne Pathog Dis; 2007; 4(3):305-12. PubMed ID: 17883314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infestation of the ductus choledochus with Fasciola hepatica. Study of human Fasciola].
    Angehrn W; Wegmann T
    Schweiz Med Wochenschr; 1975 May; 105(22):715-8. PubMed ID: 1153989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples.
    Ubeira FM; Muiño L; Valero MA; Periago MV; Pérez-Crespo I; Mezo M; González-Warleta M; Romarís F; Paniagua E; Cortizo S; Llovo J; Más-Coma S
    Am J Trop Med Hyg; 2009 Jul; 81(1):156-62. PubMed ID: 19556582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.